These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19586676)

  • 1. Multiple variants in toll-like receptor 4 gene modulate risk of liver fibrosis in Caucasians with chronic hepatitis C infection.
    Li Y; Chang M; Abar O; Garcia V; Rowland C; Catanese J; Ross D; Broder S; Shiffman M; Cheung R; Wright T; Friedman SL; Sninsky J
    J Hepatol; 2009 Oct; 51(4):750-7. PubMed ID: 19586676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection.
    Sghaier I; Zidi S; Mouelhi L; Ghazoueni E; Brochot E; Almawi WY; Loueslati BY
    Br J Biomed Sci; 2019 Jan; 76(1):35-41. PubMed ID: 30421643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of toll-like receptor 4 polymorphism with hepatitis C virus infection in Saudi Arabian patients.
    Al-Qahtani AA; Al-Anazi MR; Al-Zoghaibi F; Abdo AA; Sanai FM; Khan MQ; Albenmousa A; Al-Ashgar HI; Al-Ahdal MN
    Biomed Res Int; 2014; 2014():357062. PubMed ID: 25177689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection.
    Patin E; Kutalik Z; Guergnon J; Bibert S; Nalpas B; Jouanguy E; Munteanu M; Bousquet L; Argiro L; Halfon P; Boland A; Müllhaupt B; Semela D; Dufour JF; Heim MH; Moradpour D; Cerny A; Malinverni R; Hirsch H; Martinetti G; Suppiah V; Stewart G; Booth DR; George J; Casanova JL; Bréchot C; Rice CM; Talal AH; Jacobson IM; Bourlière M; Theodorou I; Poynard T; Negro F; Pol S; Bochud PY; Abel L; ;
    Gastroenterology; 2012 Nov; 143(5):1244-1252.e12. PubMed ID: 22841784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
    Matsuura K; Sawai H; Ikeo K; Ogawa S; Iio E; Isogawa M; Shimada N; Komori A; Toyoda H; Kumada T; Namisaki T; Yoshiji H; Sakamoto N; Nakagawa M; Asahina Y; Kurosaki M; Izumi N; Enomoto N; Kusakabe A; Kajiwara E; Itoh Y; Ide T; Tamori A; Matsubara M; Kawada N; Shirabe K; Tomita E; Honda M; Kaneko S; Nishina S; Suetsugu A; Hiasa Y; Watanabe H; Genda T; Sakaida I; Nishiguchi S; Takaguchi K; Tanaka E; Sugihara J; Shimada M; Kondo Y; Kawai Y; Kojima K; Nagasaki M; Tokunaga K; Tanaka Y;
    Gastroenterology; 2017 May; 152(6):1383-1394. PubMed ID: 28163062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection.
    Yee LJ; Tang J; Herrera J; Kaslow RA; van Leeuwen DJ
    Genes Immun; 2000 Aug; 1(6):386-90. PubMed ID: 11196686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of complement factor 5 variants as genetic risk factors for the development of advanced fibrosis in chronic hepatitis C infection.
    Halangk J; Sarrazin C; Neumann K; Puhl G; Mueller T; Teuber G; Klinker H; Hinrichsen H; Buggisch P; Landt O; Weich V; Bergk A; Wiedenmann B; Neuhaus P; Berg T; Witt H
    J Hepatol; 2008 Sep; 49(3):339-45. PubMed ID: 18644651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients.
    Ulveling D; Le Clerc S; Cobat A; Labib T; Noirel J; Laville V; Coulonges C; Carpentier W; Nalpas B; Heim MH; Poynard T; Cerny A; Pol S; Bochud PY; Dabis F; Theodorou I; Lévy Y; Salmon D; Abel L; Dominguez S; Zagury JF; ; ;
    Hepatology; 2016 Nov; 64(5):1462-1472. PubMed ID: 27339598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Toll-like receptor polymorphisms with HIV status in North Americans.
    Willie B; Hall NB; Stein CM; Jurevic RJ; Weinberg A; Mehlotra RK; Zimmerman PA
    Genes Immun; 2014 Dec; 15(8):569-77. PubMed ID: 25253287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-β and toll-like receptor-4 polymorphisms are not associated with fibrosis in haemochromatosis.
    Wood MJ; Powell LW; Dixon JL; Subramaniam VN; Ramm GA
    World J Gastroenterol; 2013 Dec; 19(48):9366-76. PubMed ID: 24409064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of progression towards liver fibrosis and hepatocellular carcinoma by SOCS3 polymorphisms in chronic HCV-infected patients.
    Jadid FZ; Chihab H; Alj HS; Elfihry R; Zaidane I; Tazi S; Badre W; Marchio A; El Filali KM; Tahiri M; Saile R; Pineau P; Ezzikouri S; Benjelloun S
    Infect Genet Evol; 2018 Dec; 66():1-8. PubMed ID: 30172885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor 4 gene polymorphisms and preeclampsia: lack of association in a Caucasian population.
    Molvarec A; Jermendy A; Kovács M; Prohászka Z; Rigó J
    Hypertens Res; 2008 May; 31(5):859-64. PubMed ID: 18712040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Toll-like Receptors 2(TLR2) and TLR 4 Gene Variations on HCV Susceptibility, Response to Treatment and Development of Hepatocellular Carcinoma in Cirrhotic HCV Patients.
    Neamatallah M; El-Bendary M; Elalfy H; Besheer T; El-Maksoud MA; Elhammady D; Abed S; Elegezy M; Kandeel L; Eldeib D; Mousa N; Abd El-Hafeez M; El-Gilany AH; Esmat G
    Immunol Invest; 2020 May; 49(4):462-476. PubMed ID: 31615295
    [No Abstract]   [Full Text] [Related]  

  • 14. [Genetic risk factors for hepatic fibrosis in chronic liver diseases].
    Wasmuth HE; Lammert F; Matern S
    Med Klin (Munich); 2003 Dec; 98(12):754-62. PubMed ID: 14685677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver fibrosis: from animal models to mapping of human risk variants.
    Weber SN; Wasmuth HE
    Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):635-46. PubMed ID: 20955966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon gamma receptor 2 gene variants are associated with liver fibrosis in patients with chronic hepatitis C infection.
    Nalpas B; Lavialle-Meziani R; Plancoulaine S; Jouanguy E; Nalpas A; Munteanu M; Charlotte F; Ranque B; Patin E; Heath S; Fontaine H; Vallet-Pichard A; Pontoire D; Bourlière M; Casanova JL; Lathrop M; Bréchot C; Poynard T; Matsuda F; Pol S; Abel L
    Gut; 2010 Aug; 59(8):1120-6. PubMed ID: 20587546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PNPLA3 and RNF7 Gene Variants are Associated with the Risk of Developing Liver Fibrosis and Cirrhosis in an Eastern European Population.
    Kupcinskas J; Valantiene I; Varkalaitė G; Steponaitiene R; Skieceviciene J; Sumskiene J; Petrenkiene V; Kondrackiene J; Kiudelis G; Lammert F; Kupcinskas L
    J Gastrointestin Liver Dis; 2017 Mar; 26(1):37-43. PubMed ID: 28338112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of CXCL9-11 gene polymorphisms in liver fibrosis among patients with chronic hepatitis C.
    Magri MC; Alvarez MSM; Iogi AA; Alves GM; Manchiero C; Dantas BP; Prata TVG; Nunes AKDS; Tengan FM
    Pathog Dis; 2021 Mar; 79(3):. PubMed ID: 33476381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C.
    Huang H; Shiffman ML; Cheung RC; Layden TJ; Friedman S; Abar OT; Yee L; Chokkalingam AP; Schrodi SJ; Chan J; Catanese JJ; Leong DU; Ross D; Hu X; Monto A; McAllister LB; Broder S; White T; Sninsky JJ; Wright TL
    Gastroenterology; 2006 May; 130(6):1679-87. PubMed ID: 16697732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between Toll-Like Receptor 3 (TLR3) rs3775290, TLR7 rs179008, TLR9 rs352140 and Chronic HCV.
    Mosaad YM; Metwally SS; Farag RE; Lotfy ZF; AbdelTwab HE
    Immunol Invest; 2019 Apr; 48(3):321-332. PubMed ID: 30321082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.